Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale announced today that it was selected by Leidos Biomedical Research Inc. (Leidos Biomed) to abstract and structure follow-up clinical data for The Cancer Genome Atlas (TCGA) Project for submission to the National Cancer Institute’s Genomic Data Commons (GDC).The Cancer Genome Atlas (TCGA) Project BackgroundThere are 230 distinct investigators that contributed
Read More
Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant
Mothers in the U.S. Are Dying: What Are We Doing to Save Them?
The maternal mortality rate in the United States is the highest of any developed country – and the rate is rising. The US is currently the most dangerous place to give birth in the developed world.
Few to none of these maternal deaths are due to medical mismanagement. Instead, problems of access, care coordination, and inequities in health care resources and social services are at the heart of maternal death rates.
Minority women, particularly those facing socioeconomic challenges, are the
Read More
Data-Driven Precision Medicine Startup Tempus Lands $200M to Expand Into New Therapeutic Areas
Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today an additional $200M financing at a value of $3.1 billion dollars. The investors include Baillie Gifford, Franklin Templeton, NEA, Novo Holdings, Revolution Growth, and funds and accounts managed by T. Rowe Price. With this latest round, the company has raised $520 million since its founding in September 2015.Founded in 2015, Tempus has the largest
Read More
Healthcare M&A Survey: Health IT Represents the Richest Opportunity in Sector
Most healthcare mergers and acquisitions (M&A) professionals see a positive outlook for healthcare and life sciences deals next year, even as political uncertainty will be the biggest factor to upend transactions, according to a recent Merrill Insight poll of global M&A professionals.According to the poll, which included more than 200 respondents from the Americas and Europe, the Middle East and Africa (EMEA), 52% of respondents believe that the M&A market is headed in a positive
Read More
Top 5 Roadblocks to Population Health Management Adoption for Providers
The healthcare system is undergoing a transformation to restore the patient to the center of their care and to provide all patients with the highest quality care at the lowest possible price and with the best possible experience. Frequently the patient’s health journey is fragmented between multiple providers, an issue which must be addressed as a key part of any successful value-based care model.
Population health management (PHM) is an umbrella term that incorporates the multitude of payment
Read More
Verily Launches Baseline Health System Consortium with Duke, Mayo, Vanderbilt
Verily, an Alphabet company, today announced a new Project Baseline initiative, the Baseline Health System Consortium, comprised of Verily, Duke University Health System, Vanderbilt University Medical Center, University of Mississippi Medical Center, Mayo Clinic, Regional Health in South Dakota and the University of Pittsburgh. Verily launched Project Baseline in 2017 with the Project Baseline Health Study to develop the technology and tools to help researchers create a more comprehensive map of
Read More
Amgen, Syapse Partner to Develop Observational Research Analytics for Precision Oncology
Amgen, a world leader in biotechnology, and Syapse, a company powering precision medicine insights through its global provider network, today announced a precision medicine collaboration in oncology. Under the terms of the collaboration, Amgen and Syapse will develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology.Generates Insights from Real-World Evidence for Potential Use in Regulatory FilingsThis effort will identify existing patients within
Read More
FDA Approves Blockchain/IoT Pilot to Track Specialty Prescription Drugs Across 3 States
The U.S. Food and Drug Administration (FDA) has approved a multi-regional pilot studying the use of blockchain-enabled data technology to track and verify specialty prescription drugs, to ensure safety, enhance value and improve health outcomes.Blockchain Pilot Consortium & Implementation TimelineThe pilot consortium is comprised of Rymedi,Temptime/Zebra, Indiana University Health, WakeMed Health & Hospitals, Good Shepherd Pharmacy and its RemediChain project, as well as the Center for
Read More
Digital Twin Technology: Should Healthcare Jump on the Bandwagon?
While healthcare is known for not jumping to conclusions very fast when investing in new technology, the industry starts to pick up the pace. Such “newcomers” as blockchain, IoT, VR, and AR get a well-deserved appraisal and become an integral part of next-gen custom healthcare software aimed at supporting personalized treatment and predictable patient outcomes across a wide range of conditions.
We anticipate that the digital twin technology has good chances to become the next addition to the
Read More
What The Failure of Microsoft’s HealthVault Means for the Future of EHRs
Microsoft recently announced that it is officially shutting down HealthVault at the end of this year. HealthVault was Microsoft’s attempt at a web-based personal health record system. You probably never used it -- it suffered low adoption. But while HealthVault will shut down, mobile apps that collect and store your personal health information and share it with your healthcare team are poised to revolutionize medicine and wellness practice.
The downfalls of HealthVault included its focus on
Read More
